WHO ICTRP trial
Screening and identification of peripheral blood biomarkers in patients with…
ChiCTR2000030771 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000030771 |
|---|---|
| Public title | Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies |
| Scientific title | Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies |
| Primary sponsor | The Second Xiangya Hospital of CSU |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | Novel Coronavirus Pneumonia (COVID-19) |
| Interventions | Gold Standard:Clinical outcome;Index test:Based on proteomics, genomics, and epigenomics to detect molecular markers in peripheral blood of patients with mild and severe COVID-19 infection, in order to establish an early molecular marker… |
| Registration date | Mar 14, 2020 |
| Target size | Target condition:30;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: